The Texas Responsible AI Governance Act (TRAIGA) establishes a comprehensive regulatory framework for high-risk AI systems across various sectors, imposing stringent obligations on developers and deployers while aiming to prevent discrimination and ensure accountability, with enforcement primarily by the attorney general and limited rights for private litigants.
The United States Patent and Trademark Office’s new Artificial Intelligence Strategy aims to address the implications of AI on intellectual property law, focusing on inventorship, subject matter eligibility, and responsible AI use while fostering inclusive innovation and public trust.
California’s Attorney General Rob Bonta has issued legal advisories outlining new AI regulations effective January 1, 2025, emphasizing consumer protection, civil rights, and healthcare compliance to ensure transparency and accountability in the use of AI technologies.
The FDA has issued two draft guidance documents outlining recommendations for the use of artificial intelligence in the development and marketing of drugs, biologics, and medical devices, emphasizing transparency, bias mitigation, and ongoing performance monitoring to ensure safety and effectiveness.
The OECD-African Union AI Dialogue in Cairo focused on governance, capacity building, and the development of localized AI solutions, highlighting the need for an African Charter on Trustworthy AI and addressing the challenges faced by emerging economies in the global AI landscape.
The Virginia House of Delegates is reviewing HB 2121, which mandates AI developers to document and publicly disclose the origin and development history of AI-generated content, as part of broader legislative efforts to enhance transparency and consumer protection in AI technologies.
